-
Torrent Pharma posts consolidated PAT of Rs 310 crore in Q2FY21
expresspharma
October 29, 2020
The company's sub-chronic and acute segments witnessed gradual recovery during the quarter while chronic momentum continued.
-
Glenmark’s consolidated revenue rises to Rs 27,674.89 million for Q4 FY 2019-20
expresspharma
June 28, 2020
Glenmark Pharmaceuticals, a research-led global integrated pharmaceutical company announced its financial results for the fourth quarter and year ended March 31, 2020.
-
Lincoln Pharma posts net profit of Rs 9.23 crore in fourth quarter
expresspharma
June 28, 2020
Lincoln Pharmaceuticals has reported a net profit of Rs 9.23 crore for the Q4FY20 ended March 2020 as against a net profit of Rs 7.17 crore in the corresponding period last year, a growth of 28.69 per cent.
-
Alembic Pharma Q4 results: Net profit up 81 per cent to Rs 225 crore
expresspharma
April 24, 2020
The company had posted a net profit of Rs 124 crore for the corresponding period of the previous fiscal, Alembic Pharmaceuticals said in a regulatory filing.
-
Morepen Labs’ Net Profit rises by 256 per cent led by higher APIs exports
expresspharma
August 15, 2019
Morepen Laboratories Ltd. has reported a 256 per cent rise in its net profit (standalone) at Rs 8.41 crore in the first quarter (Q1) of FY 2019-20 as against Rs 2.36 crore net profit registered in the corresponding quarter of the previous fiscal.
-
Lupin Q1 net profit up 49 pc to Rs 303.05
expresspharma
August 08, 2019
Lupin has reported a 49.46 per cent rise in consolidated net profit to Rs 303.05 crore for the quarter ended June 30, 2019 on account of robust sales in India and overseas.
-
Cadila Healthcare posts Q4 net profit of Rs 460 cr
expressbpd
May 30, 2019
The company said its board has recommended a dividend of Rs 3.50 per equity share on 1,02,37,42,600 equity shares of Re 1 each for the financial year ended on March 31, 2019
-
Abbott India Q3 net profit up marginally to ₹ 117 cr
expressbpd
February 11, 2019
Revenue from operations of the company stood at ₹ 947.65 crore for the quarter
-
Alembic Pharma posts net profit of Rs 93.79 cr in Q4
financialexpress
May 21, 2018
Drug firm Alembic Pharmaceuticals reported a consolidated net profit of Rs 93.79 crore for the quarter ended March 31, 2018.
-
Lupin Q3 net profit dips 65 pc to Rs 222 cr
financialexpress
February 07, 2018
Consolidated income from operations also declined to Rs 3,900.36 crore